SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950134-07-001371
Filing Date
2007-01-26
Accepted
2007-01-26 11:56:49
Documents
2
Group Members
PHIL FROHLICHPRESCOTT GROUP AGGRESSIVE SMALL CAP II LPPRESCOTT GROUP AGGRESSIVE SMALL CAP LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d43031gsc13g.htm SC 13G 76272
2 JOINT FILING AGREEMENT d43031gexv99w1.htm EX-99.1 8091
  Complete submission text file 0000950134-07-001371.txt   86259
Mailing Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601
Business Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601 2019680980
DOV PHARMACEUTICAL INC (Subject) CIK: 0001066833 (see all company filings)

IRS No.: 223374365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-78237 | Film No.: 07555245
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 1924 S UTICA SUITEF 1120 TULSA OK 74104 9187473412
PRESCOTT GROUP CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001166152 (see all company filings)

IRS No.: 731554000 | State of Incorp.: OK | Fiscal Year End: 1231
Type: SC 13G